These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 35749226)

  • 1. Short-acting inhaled bronchodilators for cystic fibrosis.
    Smith S; Rowbotham NJ; Edwards CT
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013666. PubMed ID: 35749226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-acting inhaled bronchodilators for cystic fibrosis.
    Smith S; Edwards CT
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD012102. PubMed ID: 29253920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise versus airway clearance techniques for people with cystic fibrosis.
    Heinz KD; Walsh A; Southern KW; Johnstone Z; Regan KH
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD013285. PubMed ID: 35731672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis.
    Dawson S; Girling CJ; Cowap L; Clark-Carter D
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013766. PubMed ID: 36989170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM; Smith S
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD001506. PubMed ID: 37319354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide antibiotics (including azithromycin) for cystic fibrosis.
    Southern KW; Solis-Moya A; Kurz D; Smith S
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD002203. PubMed ID: 38411248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled anti-pseudomonal antibiotics for long-term therapy in cystic fibrosis.
    Smith S; Rowbotham NJ
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD001021. PubMed ID: 36373968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Feb; 47(2):101-119. PubMed ID: 38309959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebulised hypertonic saline for cystic fibrosis.
    Wark P; McDonald VM
    Cochrane Database Syst Rev; 2018 Sep; 9(9):CD001506. PubMed ID: 30260472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
    Skilton M; Krishan A; Patel S; Sinha IP; Southern KW
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD009841. PubMed ID: 30616300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics for people with cystic fibrosis.
    Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis.
    Main E; Rand S
    Cochrane Database Syst Rev; 2023 May; 5(5):CD002011. PubMed ID: 37144842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease.
    Maqsood U; Ho TN; Palmer K; Eccles FJ; Munavvar M; Wang R; Crossingham I; Evans DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012930. PubMed ID: 30839102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled corticosteroids with combination inhaled long-acting beta2-agonists and long-acting muscarinic antagonists for chronic obstructive pulmonary disease.
    van Geffen WH; Tan DJ; Walters JA; Walters EH
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD011600. PubMed ID: 38054551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital technology for monitoring adherence to inhaled therapies in people with cystic fibrosis.
    Smith S; Calthorpe R; Herbert S; Smyth AR
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013733. PubMed ID: 36734528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled bronchodilators for cystic fibrosis.
    Halfhide C; Evans HJ; Couriel J
    Cochrane Database Syst Rev; 2005 Oct; (4):CD003428. PubMed ID: 16235319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active cycle of breathing technique for cystic fibrosis.
    Wilson LM; Saldanha IJ; Robinson KA
    Cochrane Database Syst Rev; 2023 Feb; 2(2):CD007862. PubMed ID: 36727723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright CE; Smyth AR
    Cochrane Database Syst Rev; 2024 May; 5(5):CD009530. PubMed ID: 38700027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
    Aslam AA; Sinha IP; Southern KW
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD012040. PubMed ID: 36866921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.